|
Match
|
Document |
Document Title |
|
|
6333304 |
Therapeutic compositions containing glucosamine, collagen and a bioflavanol for repair and maintenance of connective tissue
A composition for treating arthroses in animals includes exogenous glucosamine, hydrolyzed collagen and a bioflavanol. Preferred glucosamines are glucosamine hydrochloride (HCI) and glucosamine...
|
|
|
6329349 |
Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid A and adenosine receptor agents
Materials and methods for reducing or preventing ischemic damage of the heart are disclosed. A preferred embodiment of the invention comprises methods of sequential administration of a plurality of...
|
|
|
6326361 |
Gangliosides with immunosuppressive activity
A method for suppressing immune responses in animals by administering gangliosides to the animal. Gangliosides having terminal sialic acid groups are disclosed as being especially effective as...
|
|
|
6322814 |
Manufacture of and uses for low molecular weight agars and agaroids
A process is claimed whereby an aqueous solution of agar, in which most (ideally all) 4-linked residues consist of 3,6-anhydro-L-galactose, is subjected to partial acid hydolysis and upon...
|
|
|
6316506 |
Conditioning solutions for contact lens care
Contact lens care compositions for the treatment of hard contact lenses arc disclosed. The compositions are useful for rinsing, cleaning, disinfecting and storing of hard contact lenses. The...
|
|
|
6313103 |
Pectic substance as a growth factor stabilizer
Pectic substance from Aloe Vera and other sources is used as a stabilizer and a delivery vehicle for pectin/heparin-binding proteins, such as pectin/heparin binding growth factors. Aloe pectin, a...
|
|
|
6313104 |
Organoprotective solutions
The invention relates to the use of polysulfated glycosaminoglycans having a sulfur content of at least 12.5% for producing pharmaceutical preparations for inhibiting the γ-interferon-induced...
|
|
|
6313088 |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
6310073 |
Methods and compositions to treat glycosaminoglycan-associated molecular interactions
Therapeutic compounds and methods for inhibiting a glycosaminoglycan (GAG)-associated molecular interaction in a subject, whatever its clinical setting, are described.
|
|
|
6309646 |
Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
A method is disclosed for producing a soluble conjugate vaccine, and preferably protein/polysaccharide conjugates. In this process, the polysaccharide is reacted with a reagent so as to provide a...
|
|
|
6310043 |
Treatment of bacterial infections
Compounds which bind to toxins associated with enteric bacterial infection, compositions including the compounds, methods for the neutralization of toxins in a patient, and methods for the...
|
|
|
6306836 |
Peritoneal dialysis solutions containing maltodextrins and amino acids
A peritoneal dialysis solution comprising as osmotic agents approximately 2.0 to about 6.0% (w/v) maltodextrins and approximately 0.25 to about 2.0% (w/v) amino acids. The peritoneal dialysis...
|
|
|
6306453 |
Anti-stress agents for aquatic animals
The present invention concerns anti-stress agents for improving the resistance of aquatic animals and especially of fish, shrimps and invertebrates in fresh and sea water in the case of strains of...
|
|
|
6303587 |
Composition and method for stimulating pollen germination
Composition for application, in particular to leaves, comprising an excipient, the conventional constituents of compositions for application, in particular to leaves, and an active ingredient,...
|
|
|
6303114 |
IL-12 enhancement of immune responses to T-independent antigens
The present invention relates to a method of modulating an immune response to a T-cell or thymus independent antigen in a host (e.g., mammalian, including human), comprising administering to the...
|
|
|
6303584 |
Water soluble lipidated arabinogalactan
Arabinogalactan compositions are provided which are useful in a wide variety of different biomedical applications. In one embodiment, water soluble lipidated arabinogalactans are provided which...
|
|
|
6303580 |
Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity
The present invention provides for an isolated A-type substance having a structure identical to an A-type substance obtained from human liver or placenta, which is a cyclical containing...
|
|
|
6303586 |
Supportive therapy for diabetes, hyperglycemia and hypoglycemia
Methods for controlling serum glucose level in a mammal comprising ingesting a stabilized rice bran derivative selected from the group consisting of a solubilized fraction, an insolubilized...
|
|
|
6303585 |
Cross-linked polysaccharide drug carrier
A carrier and a method for preparing it are provided for use in the delivery of therapeutic agents. A polysaccharide is reacted with an oxidizing agent to open sugar rings on the polysaccharide to...
|
|
|
6299897 |
Inhibition of selectin binding
This invention provides compositions for inhibiting the binding between two cells, one expressing P- or L-selectin on the surface and the other expressing the corresponding ligand. A covalently...
|
|
|
6299881 |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
A method for producing a conjugate vaccine includes mixing a uronium salt reagent with a first moiety (e.g., a polysaccharide). According to the invention, the uronium salt reagent has a chemical...
|
|
|
6299878 |
Transferrin glycans composition for the induction of immune tolerance
The invention pertains to a process for the production of a pharmaceutical composition effective for controlling in a recipient mammalian host, particularly man, immune reactions of the type that...
|
|
|
6296892 |
Beverages for enhanced physical performance
The present invention discloses an isotonic beverage product for direct increase of the muscular ATP level consisting essentially of a solution of D-ribose and blood glucose increasing...
|
|
|
6294523 |
Extended type 1 chain glycosphingolipids as tumor-associated antigens
A variety of compounds are provided which are useful as immunogens and as tumor markers. The present invention discloses methods relating to the detection of cancer. Extended forms of the...
|
|
|
6288043 |
Injectable hyaluronate-sulfated polysaccharide conjugates
An injectable composition is provided for promoting bone and/or cartilage growth comprising hyaluronic acid cross-linked to sulfated polysaccharide through linking groups. The linking groups are...
|
|
|
6288044 |
O-sulfated bacterial polysaccharides
Process for the preparation of O-sulfated K4, K5 and K40 polysaccharides useful for the treatment of tumoral, HIV-1 and coagulation pathologies and in cosmetic preparations, wherein the K4, K5 or...
|
|
|
6284744 |
Peritoneal induced medicaments
A solution of hyaluronic acid and water-soluble salts thereof in a pharmaceutically acceptable media in which the hyaluronic acid concentration is at least about 0.4% by weight based on the weight...
|
|
|
6284745 |
Gel compositions
The present invention provides a sustained-release composition obtained by gelating a compound such as a drug together with an oil or polysaccharide. This composition enables excellent sustained...
|
|
|
6280738 |
Non-IgA Fc binding forms of the group B streptococcal β antigens
A-X 202 X 203 X 204 X 205 X 206 X 207 X 208 X 209 X 210 X 211 X 212 X 213 -B, wherein A represents amino acid residues 38-201 of SEQ ID NO: 2, B represents a sequence starting from...
|
|
|
6277815 |
Solution for peritoneal dialysis
A solution for peritoneal dialysis or for infusion comprises two single solutions which, after heat sterilization, are brought together and dispensed, with the first single solution containing...
|
|
|
6274565 |
Inhibitor of activation of β-glucan recognition protein
The present invention relates to an inhibitor of an activation of β-glucan recognition protein in a body fluid of an insect comprising a sugar compound comprising plural member of sugar residues,...
|
|
|
6274566 |
Methods for treating mammals with modified alginates and pectins
A method for binding tumor emboli circulating in the blood of mammals is provided by oral or intravenous administration of a modified alginate, prepared from alginic acid by thermal...
|
|
|
6271216 |
Stable solution of hyaluronate in a balanced salt medium
A stable physiologic balanced salt solution of a hyaluronate salt, such as sodium hyaluronate, is provided which contains calcium ion, for example, in the form of calcium chloride or calcium...
|
|
|
6271215 |
Sulfated oligosaccharides having anticoagulant/antithrombotic activity
A method for the anticoagulant and/or antithrombotic treatment of a human or other warm-blooded animal patient in need of such treatment, comprises administration to the patient of an effective...
|
|
|
6271214 |
Process for the preparation of immunomodulatory polysaccharides from aloe
The present invention provides a rapid and efficient method for the preparation and isolation of biologically active polysaccharides from Aloe. The present invention includes the activated mixture...
|
|
|
6258383 |
Dietary supplement combining colostrum and lactoferrin in a mucosal delivery format
A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing....
|
|
|
6255291 |
Composition and method for treating cancer and immunological disorders resulting in chronic conditions
A composition containing alph-alanine, adenosine compound and a glucan. Methods for treating cancer and immunological disorders with said composition.
|
|
|
6255295 |
Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
A composition for the protection, treatment and repair and for reducing the inflammation of connective tissue in mammals and a method for the protection, treatment of connective tissue in mammals...
|
|
|
6251877 |
Composition for external application containing a β-1,6-branched-β-1,3-glucan
Disclosed herein is a process for liquid cultivating Schizophyllum commune Fr. for isolation of β-1,6-branched-β-1,3-glucan and a composition for external application containing...
|
|
|
6251876 |
Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
The present invention relates to compositions containing an autocross-linked form of hyaluronic acid as a first component in a mixture with a second component noncross-linked hyaluronic acid, and...
|
|
|
6251878 |
Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides
Methods and compositions are disclosed for the prevention and/or treatment of immunological damage to skin exposed to ultraviolet irradiation. The compositions described herein include biologically...
|
|
|
6248726 |
Method of peritoneal dialysis using glucose polymer solutions
There is described polysaccharides of high molecular weight for use in peritoneal dialysis. The polysaccharides are capable of dialysing human serum for long periods of time without causing damage...
|
|
|
6248734 |
Use of photodynamic therapy for prevention of secondary cataracts
Photodynamic therapy to prevent secondary cataracts is effected using photosensitizers such as green porphyrins as photoactive agents to destroy remnant lens epithelial cells.
|
|
|
RE37234 |
Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
Disclosed are nitrosated and/or nitrosylated phosphodiesterase inhibitors having the formula NO n -PDE inhibitor where n is 1 or 2. The invention also provides compositions comprising such...
|
|
|
6245752 |
Compositions and methods for tolerization in immune complex-mediated disease progression
Methods and compositions are provided for tolerizing shed antigen-specific B cells involved in an immune complex-mediated disease progression. The composition comprises a substantially...
|
|
|
6245753 |
Amphiphilic polysaccharide derivatives
Polysaccharides, which are widely used as an anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong...
|
|
|
6235726 |
Water insoluble derivatives of polyanionic polysaccharides
A water insoluble, biocompatible composition that includes the reaction product of a polyanionic polysaccharide and an activating agent.
|
|
|
6235725 |
Methods and compositions for the prevention of tolerance to medications
The present invention pertains to the identification of moieties and methods of using the same for preventing tolerance to bronchodilators. More specifically, the present invention pertains to the...
|
|
|
6235305 |
Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
This invention provides lipase inhibitors that have been rendered non-absorbable by linking such lipase inhibitors to a non-absorbable support, pharmaceutical comprising such lipase inhibitors and...
|
|
|
6232301 |
Remedies for bladder disorders
In order to provide an agent for treatment of bladder troubles that has vesical mucosa epithelium dilatation promoting action and/or vesical mucosa healing action, and exhibits excellent curative...
|